LivingGLP1
Study S000836

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

ClinicalTrials.gov record

Registration

Registration
NCT06975111
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE2; PHASE3
Masking
NONE
Status
RECRUITING
Enrollment
200
Start
2026-03-01
Primary completion
2029-10-31
Lead sponsor
University of Colorado, Denver
Conditions
Menopause; Menopause Hot Flashes; Menopause Related Conditions; Cardiovascular
Interventions
DRUG:Metformin; DRUG:semaglutide; DRUG:Anti-hypertensives; DRUG:Lipid Lowering Medication; BEHAVIORAL:Life style intervention; DRUG:Fezolinetant; DRUG:Hormonal therapy
Results posted
FALSE
Individual participant data sharing
UNDECIDED
Secondary identifiers
OTHER:U1111-1322-1036

Registered primary outcomes

  • Epigenetic aging measurements of "PhenoAge" [Up to 2 years]
  • Epigenetic aging measurements of "GrimAge" [Up to 2 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.